Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells.

Spiller OB, Morgan BP, Tufaro F, Devine DV.

Eur J Immunol. 1996 Jul;26(7):1532-8.

PMID:
8766557
2.

Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.

Gorter A, Blok VT, Haasnoot WH, Ensink NG, Daha MR, Fleuren GJ.

Lab Invest. 1996 Jun;74(6):1039-49.

PMID:
8667608
4.

Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas.

Goslings WR, Blom DJ, de Waard-Siebinga I, van Beelen E, Claas FH, Jager MJ, Gorter A.

Invest Ophthalmol Vis Sci. 1996 Aug;37(9):1884-91.

PMID:
8759358
5.

Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.

Schmitt CA, Schwaeble W, Wittig BM, Meyer zum Büschenfelde KH, Dippold WG.

Eur J Cancer. 1999 Jan;35(1):117-24.

PMID:
10211099
6.
7.

Complement regulatory proteins in normal human esophagus and esophageal squamous cell carcinoma.

Shimo K, Mizuno M, Nasu J, Hiraoka S, Makidono C, Okazaki H, Yamamoto K, Okada H, Fujita T, Shiratori Y.

J Gastroenterol Hepatol. 2004 Jun;19(6):643-7.

PMID:
15151618
8.

HIV-1 and HIV-2 isolates differ in their ability to activate the complement system on the surface of infected cells.

Marschang P, Gürtler L, Tötsch M, Thielens NM, Arlaud GJ, Hittmair A, Katinger H, Dierich MP.

AIDS. 1993 Jul;7(7):903-10.

PMID:
7689323
9.

Immunization against tumor cell surface complement-regulatory proteins.

Durrant LG, Spendlove I.

Curr Opin Investig Drugs. 2001 Jul;2(7):959-66. Review.

PMID:
11757799
10.

Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.

Koski CL, Estep AE, Sawant-Mane S, Shin ML, Highbarger L, Hansch GM.

J Neurochem. 1996 Jan;66(1):303-12.

PMID:
8522968
11.

Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro.

Geis N, Zell S, Rutz R, Li W, Giese T, Mamidi S, Schultz S, Kirschfink M.

Curr Cancer Drug Targets. 2010 Dec;10(8):922-31.

PMID:
20879979
12.
13.

Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.

Brasoveanu LI, Altomonte M, Fonsatti E, Colizzi F, Coral S, Nicotra MR, Cattarossi I, Cattelan A, Natali PG, Maio M.

Lab Invest. 1996 Jan;74(1):33-42.

PMID:
8569195
14.
15.

Down-regulation of HLA-G1 cell surface expression in human cytomegalovirus infected cells.

Pizzato N, Garmy-Susini B, Le Bouteiller P, Lenfant F.

Am J Reprod Immunol. 2003 Oct;50(4):328-33.

PMID:
14672336
18.

Apoptosis induced by human cytomegalovirus infection can be enhanced by cytokines to limit the spread of virus.

Chaudhuri AR, St Jeor S, Maciejewski JP.

Exp Hematol. 1999 Jul;27(7):1194-203.

PMID:
10390195
20.

Supplemental Content

Support Center